Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP8 | Q6V1X1 | 16/20 | 0.34 |
| ▸ | DPP9 | Q86TI2 | 16/20 | 0.34 |
| ▸ | GLMN | Q92990 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4866033 | 0.83 | DPP8 (0.35) | DPP8DPP9GLMNDPP4 | |
| SCHEMBL4863543 | 0.81 | PKM (0.35) | PKML3MBTL1 | |
| Phenyl Vinyl Sulfide SCHEMBL30733441 | 0.75 | CYP19A1 (0.36) | EPHX1P2RX7 | |
| SCHEMBL4863268 | 0.74 | PKM (0.33) | PKML3MBTL1 | |
| SCHEMBL822780 | 0.73 | ALDH1A1 (0.36) | DPP8DPP9GLMN | |
| SCHEMBL4864687 | 0.72 | DPP8 (0.33) | DPP8DPP9GLMNP2RX7 | |
| SCHEMBL10483602 | 0.71 | CYP17A1 (0.47) | DPP8DPP9L3MBTL1 | |
| SCHEMBL4864920 | 0.71 | THRB (0.33) | P2RX7 | |
| SCHEMBL4856991 | 0.70 | PKM (0.31) | PKML3MBTL1 | |
| SCHEMBL4863639 | 0.70 | MEN1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7456311-B2 | Adamantane derivative, process for producing the same, and photosensitive material for photoresist | IDEMITSU KOSAN CO., LTD. (JP) | 2008-11-25 | — | — | US | disclosed |
| US-20080009647-A1 | Adamantane Derivative, Process for Producing the Same, and Photosensitive Material for Photoresist | IDEMITSU KOSAN CO., LTD. (JP) | 2008-01-10 | — | — | US | disclosed |
| EP-1803708-A1 | ADAMANTANE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND PHOTOSENSITIVE MATERIAL FOR PHOTORESIST | IDEMITSU KOSAN CO., LTD. (JP) | 2007-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080009647-A1 | Adamantane Derivative, Process for Producing the Same, and Photosensitive Material for Photoresist | LSS, C1S, DHPS | DPP8 4002/4885DPP9 3822/4885GLMN 4526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.